Factory expansion MYCOPHYTO has announced a €16 million round to increase production capacity and build its first factory with sustainable technologies, signaling a scalable supply chain and potential for larger orders of biostimulants and soil regeneration solutions.

Regenerative agriculture focus The company sells biostimulants and soil-regeneration solutions that reduce water and synthetic fertilizer use, aligning with agri-tech buyers prioritizing sustainable, drought-resilient crops and lower input costs.

AI and biotech edge A unique combination of arbuscular mycorrhizal fungi knowledge, a biobank, predictive IT, and AI positions MYCOPHYTO to offer territory- and crop-specific microbiome solutions, appealing to researchers and large-scale growers seeking precision soil microbe programs.

Early-stage revenue With revenue under one million and a total funding pool of around $32 million, the company is financially positioned for growth but may still require channel partners or pilot programs to de-risk large-scale deployments and demonstrate ROI to new customers.

Global expansion potential Recent financing and a clear push toward production capacity suggest opportunities across regions with water scarcity and fertilizer-decarbonization mandates, including horticulture, row crops, and specialty crops that rely on soil health and microbial inputs.